Register to receive a free U.S. Market Report Suite for Orthopedic Trauma Devices – MedSuite report synopsis and brochure
OrthoXel, a specialist orthopaedic trauma company, has announced results of a new study showing early healing in high-risk patients who were candidates for compromised fracture healing based on their injury characteristics or comorbidities. The report highlights successful uncomplicated clinical union after being treated with the use of the Apex Tibial Nailing System, which utilizes the micro-motion locking mode to promote bony callus formation.
Nonunion, a well-known complication, occurs in approximately 7-19% of all tibial fractures treated in Level I Trauma Centers. In these specific cases taken from the ongoing observational study of tibial fracture healing following Apex micromotion fixation, high-risk patients achieved clinical union quickly and achieved a full return to mobility, despite having injury patterns and comorbidities which are known to increase the risk of nonunion.
“This white paper is really interesting given the results I have seen in these challenging surgical cases,” said Professor James Harty, Orthopaedic Surgeon from Cork University Hospital, Ireland. “The Apex Tibial Nailing system in micromotion mode has proven itself so far with these high-risk fracture patients, all of whom showed outstanding healing results.”
Overall, the U.S. orthopedic trauma device market was valued at $3.6 billion in 2018. This is expected to increase over the forecast period at a CAGR of 3.5% to exceed $4.5 billion. Trauma, back pain and arthritis are the three most common musculoskeletal conditions reported. The aging of the population is one of the drivers for the increasing number of the musculoskeletal diseases every year. Internationally, musculoskeletal conditions are the most common causes of chronic disability. In terms of OrthoXel’s study, the results of early healing in high-risk cases is quite profound, as this is a growing segment.
“In this observational study, we are leveraging some exciting new imaging techniques to view 3D models of each injury at 12 weeks after surgery and virtually assess the mechanical properties of the newly formed bone,” said Hannah Dailey, Co-Founder & Chief Scientist Officer at OrthoXel. “This innovative analysis technique has been recently published in leading journals and provides extraordinary quantitative and unbiased insight into the healing process.”
For Further Information
More on the orthopedic trauma devices market in the U.S can be found in a series of reports published by iData Research entitled the U.S. Market Report Suite for Orthopedic Trauma Devices.